sgRNA amount is a limiting factor in adenine base editing using RNA LNPs
Alexandra Birkenshaw(University of British Columbia), Colin J.D. Ross(BC Children's Hospital), Tyler Thomson(University of Toronto), Anna K. Blakney(University of British Columbia), Ana Timpano(University of British Columbia), Cassie Huang(University of Pennsylvania), Yui Komaki(University of British Columbia), Mai P. Truong(University of British Columbia), Jayesh A. Kulkarni(FPInnovations), Nadine Ramsden(University of British Columbia), Daniel Z. Kurek(FPInnovations)
Cited by 2
Related Papers
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
|International Journal of Pharmaceutics|2021|1.5k
The current landscape of nucleic acid therapeutics
|Nature Nanotechnology|2021|1.3k
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
|Advanced Drug Delivery Reviews|2022|1.1k